Physician profile
Martha E Schmitz
NPI 1881601136
$1,789.14
in general payments reported to CMS, 2019-2025
26 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $294 · 2021: $281 · 2022: $243 · 2023: $235 · 2024: $188 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.37 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.46 | 2019-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $246.91 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $136.94 | 2022-2025 | |
| Hologic Sales and Service, LLC | $128.69 | 2021-2025 | Aptima, Myosure Tissue Removal Device, Omni Hysteroscope |
| Millicent US INC | $120.12 | 2023-2025 | Intrarosa |
| Therapeuticsmd, INC. | $112.71 | 2019-2021 | |
| Shield Therapeutics INC | $91.69 | 2022-2024 | |
| Astellas Pharma US INC | $53.29 | 2022-2024 | Veozah |
| Lupin INC. | $35.47 | 2020 | |
| Agile Therapeutics, INC. | $33.58 | 2022 | |
| Scynexis, INC. | $30.23 | 2022 | |
| Coloplast Corp | $29.95 | 2021 | |
| Acessa Health INC. | $24.62 | 2019 | |
| Sumitomo Pharma America, INC. | $22.25 | 2024 | Myfembree |
| Evofem Biosciences, INC. | $21.68 | 2023 | Phexxi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $21.64 | 2022 | |
| Radiometer America, INC | $21.38 | 2025 | |
| Dilon Technologies, INC. | $20.03 | 2024 | Hemoblast Bellows |
| Mylan Pharmaceuticals INC. | $19.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.73 | 2020 | |
| Merck Sharp & Dohme LLC | $18.04 | 2020 | |
| Exact Sciences Corporation | $17.92 | 2023 | Cologuard Collection Kit |
| Ascend Therapeutics US, LLC | $16.75 | 2023 | |
| Organon LLC | $15.37 | 2021 | |
| Mission Pharmacal Company | $12.14 | 2021 | |
| Davol INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.